Concepedia

Author

Arnon Nagler

Sheba Medical Center

Also Known As

A. Nagler, Arnon Nagler, Hillel Halkin

26

Publications

281

Citations

7

H-Index

28

Concepts

All Affiliations

Sheba Medical CenterTel Aviv UniversityInsermCharité - Universitätsmedizin BerlinHôpital Saint-Antoine
AN

About

Arnon Nagler is an author at Sheba Medical Center specializing in medicine, marrow transplantation, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

78

2

Cell Biology

2

2

41

3

Cellular Therapies

2

2

64

4

Health Sciences

1

1

27

5

Blood Transplantation

1

1

37

Arnon Nagler

×

6

Publications

250

Citations

6

H-Index

YearCitations

Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Federico Lussana, Alessandro Rambaldi, Maria Chiara Finazzi,

Haematologica

2014

72

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

Hildegard Greinix, Dirk‐Jan Eikema, Linda Köster,

Haematologica

2021

65

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

M. T. Rubio, Myriam Labopin, Didier Blaise,

Haematologica

2015

37

The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway

Katia Beider, Evgenia Rosenberg, Hanna Bitner,

Clinical Cancer Research

2016

35

Tumor Necrosis Factor Promotes Human T‐Cell Development in Nonobese Diabetic/Severe Combined Immunodeficient Mice

Christophe Ferrand, Amnon Peled, Arnon Nagler,

Stem Cells

2004

27

The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators

Katia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein,

Biochemical Pharmacology

2019

14

Page 1